Literature DB >> 33140678

Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia.

Vera Adema1, Jack Khouri2, Ying Ni3, Heesun J Rogers4, Cassandra M Kerr1, Hassan Awada1, Yasunobu Nagata1, Teodora Kuzmanovic1, Anjali S Advani2, Aaron T Gerds2, Sudipto Mukherjee2, Aziz Nazha2, Yogen Saunthararajah1,2, Yazan Madanat2, Bhumika J Patel2, Francesc Solé5, Steffan T Nawrocki6, Jennifer S Carew6, Mikkael A Sekeres1,2, Jaroslaw P Maciejewski1,2, Valeria Visconte1, Hetty E Carraway2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33140678      PMCID： PMC8672448          DOI： 10.1080/10428194.2020.1839647

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts.

Authors:  V Visconte; H Makishima; A Jankowska; H Szpurka; F Traina; A Jerez; C O'Keefe; H J Rogers; M A Sekeres; J P Maciejewski; R V Tiu
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

2.  Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.

Authors:  Uwe Platzbecker; Ulrich Germing; Katharina S Götze; Philipp Kiewe; Karin Mayer; Jörg Chromik; Markus Radsak; Thomas Wolff; Xiaosha Zhang; Abderrahmane Laadem; Matthew L Sherman; Kenneth M Attie; Aristoteles Giagounidis
Journal:  Lancet Oncol       Date:  2017-09-01       Impact factor: 41.316

3.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

4.  Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.

Authors:  Esther A Obeng; Ryan J Chappell; Michael Seiler; Michelle C Chen; Dean R Campagna; Paul J Schmidt; Rebekka K Schneider; Allegra M Lord; Lili Wang; Rutendo G Gambe; Marie E McConkey; Abdullah M Ali; Azra Raza; Lihua Yu; Silvia Buonamici; Peter G Smith; Ann Mullally; Catherine J Wu; Mark D Fleming; Benjamin L Ebert
Journal:  Cancer Cell       Date:  2016-09-12       Impact factor: 31.743

5.  Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.

Authors:  J Broséus; T Alpermann; M Wulfert; L Florensa Brichs; S Jeromin; E Lippert; M Rozman; F Lifermann; V Grossmann; T Haferlach; U Germing; E Luño; F Girodon; S Schnittger
Journal:  Leukemia       Date:  2013-04-18       Impact factor: 11.528

Review 6.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

7.  Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.

Authors:  Rachel B Darman; Michael Seiler; Anant A Agrawal; Kian H Lim; Shouyong Peng; Daniel Aird; Suzanna L Bailey; Erica B Bhavsar; Betty Chan; Simona Colla; Laura Corson; Jacob Feala; Peter Fekkes; Kana Ichikawa; Gregg F Keaney; Linda Lee; Pavan Kumar; Kaiko Kunii; Crystal MacKenzie; Mark Matijevic; Yoshiharu Mizui; Khin Myint; Eun Sun Park; Xiaoling Puyang; Anand Selvaraj; Michael P Thomas; Jennifer Tsai; John Y Wang; Markus Warmuth; Hui Yang; Ping Zhu; Guillermo Garcia-Manero; Richard R Furman; Lihua Yu; Peter G Smith; Silvia Buonamici
Journal:  Cell Rep       Date:  2015-10-22       Impact factor: 9.423

8.  SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.

Authors:  Luca Malcovati; Mohsen Karimi; Elli Papaemmanuil; Ilaria Ambaglio; Martin Jädersten; Monika Jansson; Chiara Elena; Anna Gallì; Gunilla Walldin; Matteo G Della Porta; Klas Raaschou-Jensen; Erica Travaglino; Klaus Kallenbach; Daniela Pietra; Viktor Ljungström; Simona Conte; Emanuela Boveri; Rosangela Invernizzi; Richard Rosenquist; Peter J Campbell; Mario Cazzola; Eva Hellström Lindberg
Journal:  Blood       Date:  2015-05-08       Impact factor: 22.113

9.  Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

Authors:  E Papaemmanuil; M Cazzola; J Boultwood; L Malcovati; P Vyas; D Bowen; A Pellagatti; J S Wainscoat; E Hellstrom-Lindberg; C Gambacorti-Passerini; A L Godfrey; I Rapado; A Cvejic; R Rance; C McGee; P Ellis; L J Mudie; P J Stephens; S McLaren; C E Massie; P S Tarpey; I Varela; S Nik-Zainal; H R Davies; A Shlien; D Jones; K Raine; J Hinton; A P Butler; J W Teague; E J Baxter; J Score; A Galli; M G Della Porta; E Travaglino; M Groves; S Tauro; N C Munshi; K C Anderson; A El-Naggar; A Fischer; V Mustonen; A J Warren; N C P Cross; A R Green; P A Futreal; M R Stratton; P J Campbell
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

10.  Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes.

Authors:  H Dolatshad; A Pellagatti; F G Liberante; M Llorian; E Repapi; V Steeples; S Roy; L Scifo; R N Armstrong; J Shaw; B H Yip; S Killick; R Kušec; S Taylor; K I Mills; K I Savage; C W J Smith; J Boultwood
Journal:  Leukemia       Date:  2016-05-23       Impact factor: 11.528
View more
  1 in total

Review 1.  Causes and Pathophysiology of Acquired Sideroblastic Anemia.

Authors:  Juan Jose Rodriguez-Sevilla; Xavier Calvo; Leonor Arenillas
Journal:  Genes (Basel)       Date:  2022-08-30       Impact factor: 4.141
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.